David Schaffer, Director at 4D Molecular Therapeutics Inc. (FDMT), sold 57,812 shares at $26.69 ($1.6M) on 2021-09-30, disclosed to the SEC on 2021-10-01.
Open-market sale of $1.6M FDMT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.99 | 7,806 | $218K | 13.6% |
| 2 | $27.99 | 7,806 | $218K | 13.6% |
| 3 | $29.06 | 8,365 | $243K | 15.1% |
| 4 | $29.06 | 8,365 | $243K | 15.1% |
| 5 | $30.06 | 700 | $21K | 1.3% |
| 6 | $26.69 | 7,836 |
| $209K |
| 13.0% |
| 7 | $26.69 | 7,836 | $209K | 13.0% |
| 8 | $27.28 | 4,549 | $124K | 7.7% |
| 9 | $27.28 | 4,549 | $124K | 7.7% |
| Total | $27.86 avg | 57,812 | $1.6M | 100% |
| Filing → |
| QURE | SELL | 2020-01-30 | $100K | — | Filing → |
| QURE | SELL | 2019-01-30 | $38K | — | Filing → |
| QURE | SELL | 2019-01-29 | $230K | — | Filing → |